BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6235885)

  • 1. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
    Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
    Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 51Cr-EDTA/99Tcm-MDP ratio: a simple non-invasive method for assessing renal osteodystrophy.
    Nisbet AP; Shaw P; Taube D; Edwards S; Maisey MN; Mashiter G
    Br J Radiol; 1989 May; 62(737):438-42. PubMed ID: 2496884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on diphosphonate kinetics. Part I: Evaluation of plasma elimination curves during 24 h.
    Hyldstrup L; McNair P; Ring P; Henriksen O
    Eur J Nucl Med; 1987; 12(12):581-4. PubMed ID: 3107990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
    Park-Holohan SJ; Blake GM; Fogelman I
    Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diphosphonate space: a useful quantitative index of disease activity in patients undergoing hydroxy methylene diphosphonate (HMDP) bone imaging for Paget's disease [corrected].
    Evans A; Perkins A; Wastie M; Stone M; Hosking D
    Eur J Nucl Med; 1991; 18(9):757-9. PubMed ID: 1809266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Paget's disease with quantitative assessment of tracer kinetics.
    Gnanasegaran G; Moore AE; Blake GM; Vijayanathan S; Clarke SE; Fogelman I
    Clin Nucl Med; 2007 Oct; 32(10):765-9. PubMed ID: 17885354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct in vivo measurement of 99mTc-methylene diphosphonate protein binding.
    Blake GM; Moore AE; Park-Holohan SJ; Fogelman I
    Nucl Med Commun; 2003 Jul; 24(7):829-35. PubMed ID: 12813203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple method for estimating the skeletal uptake of diphosphonates.
    Galli G; Bagnato A; Galli M
    Nucl Med Commun; 1995 Sep; 16(9):773-8. PubMed ID: 7478410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
    Watt I; Hill P
    Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
    Moore AE; Blake GM; Fogelman I
    J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of renal failure and metabolic diseases upon bone scanning in children.
    Schümichen C
    Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830
    [No Abstract]   [Full Text] [Related]  

  • 12. Diphosphonates in the evaluation of metabolic bone disease.
    Fogelman I; Smith ML
    Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromium-51-EDTA clearance in adults with a single-plasma sample.
    Mårtensson J; Groth S; Rehling M; Gref M
    J Nucl Med; 1998 Dec; 39(12):2131-7. PubMed ID: 9867156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
    Blake GM; Moore AE; Fogelman I
    Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of the kinetics of bone concentration of mdp-tc 99m in Paget's disease and various treatment methods].
    de La Rochefoucauld B; Basset JY; Rondier J; Cayla J; Ancri D
    Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):575-9. PubMed ID: 6241965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of bone gammagraphy with Tc99-methyldiphosphonate (gamma G Tc99-MDP) in renal osteodystrophy].
    Garciá Garciá M; Vallés Prats M; López Pedret J; Pons Creus JM; Botey Puig A; Herranz G-Romero R; Setoain Quinquer J; Revert Torrellas L
    Rev Clin Esp; 1981 Apr; 161(1):31-5. PubMed ID: 6454934
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
    Hyldstrup L; McNair P; Ring P; Henriksen O
    Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone scintigraphy with 99Tcm polyphosphate in uremic osteodystrophy].
    Meneghello A; Bertoli M; Naso A; Casara D; Camposampiero A; Presacco D
    Radiol Med; 1980 Oct; 66(10):760-1. PubMed ID: 6452654
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
    Moore AE; Blake GM; Fogelman I
    J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.